BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hickey CA, Beattie TJ, Cowieson J, Miyashita Y, Strife CF, Frem JC, Peterson JM, Butani L, Jones DP, Havens PL, Patel HP, Wong CS, Andreoli SP, Rothbaum RJ, Beck AM, Tarr PI. Early volume expansion during diarrhea and relative nephroprotection during subsequent hemolytic uremic syndrome. Arch Pediatr Adolesc Med 2011;165:884-9. [PMID: 21784993 DOI: 10.1001/archpediatrics.2011.152] [Cited by in Crossref: 83] [Cited by in F6Publishing: 64] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Igarashi T, Ito S, Sako M, Saitoh A, Hataya H, Mizuguchi M, Morishima T, Ohnishi K, Kawamura N, Kitayama H. Guidelines for the management and investigation of hemolytic uremic syndrome. Clin Exp Nephrol. 2014;18:525-557. [PMID: 25099085 DOI: 10.1007/s10157-014-0995-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
2 Loos S, Ahlenstiel T, Kranz B, Staude H, Pape L, Härtel C, Vester U, Buchtala L, Benz K, Hoppe B, Beringer O, Krause M, Müller D, Pohl M, Lemke J, Hillebrand G, Kreuzer M, König J, Wigger M, Konrad M, Haffner D, Oh J, Kemper MJ. An outbreak of Shiga toxin-producing Escherichia coli O104:H4 hemolytic uremic syndrome in Germany: presentation and short-term outcome in children. Clin Infect Dis 2012;55:753-9. [PMID: 22670043 DOI: 10.1093/cid/cis531] [Cited by in Crossref: 100] [Cited by in F6Publishing: 79] [Article Influence: 10.0] [Reference Citation Analysis]
3 Davis TK, Van De Kar NCAJ, Tarr PI, Sperandio V, Hovde CJ. Shiga Toxin/Verocytotoxin-Producing Escherichia coli Infections: Practical Clinical Perspectives. Microbiol Spectr 2014;2. [DOI: 10.1128/microbiolspec.ehec-0025-2014] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
4 Cheung V, Trachtman H. Hemolytic uremic syndrome: toxins, vessels, and inflammation. Front Med (Lausanne) 2014;1:42. [PMID: 25593915 DOI: 10.3389/fmed.2014.00042] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
5 Preußel K, Höhle M, Stark K, Werber D. Shiga toxin-producing Escherichia coli O157 is more likely to lead to hospitalization and death than non-O157 serogroups--except O104. PLoS One 2013;8:e78180. [PMID: 24244292 DOI: 10.1371/journal.pone.0078180] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
6 Tarr PI, Karpman D. Editorial commentary: Escherichia coli O104:H4 and hemolytic uremic syndrome: the analysis begins. Clin Infect Dis 2012;55:760-3. [PMID: 22670035 DOI: 10.1093/cid/cis533] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
7 Ardissino G, Daccò V, Testa S, Civitillo CF, Tel F, Possenti I, Belingheri M, Castorina P, Bolsa-ghiringhelli N, Tedeschi S, Paglialonga F, Salardi S, Consonni D, Zoia E, Salice P, Chidini G. Hemoconcentration: a major risk factor for neurological involvement in hemolytic uremic syndrome. Pediatr Nephrol 2015;30:345-52. [DOI: 10.1007/s00467-014-2918-0] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
8 Estrada-garcia T, Hodges K, Hecht GA, Tarr PI. Escherichia coli. Foodborne Infections and Intoxications. Elsevier; 2013. pp. 129-64. [DOI: 10.1016/b978-0-12-416041-5.00008-1] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
9 Qin X, Klein EJ, Galanakis E, Thomas AA, Stapp JR, Rich S, Buccat AM, Tarr PI. Real-Time PCR Assay for Detection and Differentiation of Shiga Toxin-Producing Escherichia coli from Clinical Samples. J Clin Microbiol. 2015;53:2148-2153. [PMID: 25926491 DOI: 10.1128/jcm.00115-15] [Cited by in Crossref: 31] [Cited by in F6Publishing: 16] [Article Influence: 4.4] [Reference Citation Analysis]
10 Loos S, Oh J, van de Loo L, Kemper MJ, Blohm M, Schild R. Hemoconcentration and predictors in Shiga toxin-producing E. coli-hemolytic uremic syndrome (STEC-HUS). Pediatr Nephrol 2021. [PMID: 34046736 DOI: 10.1007/s00467-021-05108-6] [Reference Citation Analysis]
11 Auschra C, Kielstein JT, Tecklenburg A, Müller-Seitz G. [After the crisis is before the crisis: Coping-strategies for public health emergency situations on different levels--experiences of the German E. coli outbreak 2011]. MMW Fortschr Med 2014;156 Suppl 4:115-9. [PMID: 26153590 DOI: 10.1007/s15006-014-3757-4] [Reference Citation Analysis]
12 Wang YL, Chen JH, Zhu QF, Yu GF, Luo CF, Luo GJ, Li SR, Hei ZQ. In Vivo Evaluation of the Ameliorating Effects of Small-Volume Resuscitation with Four Different Fluids on Endotoxemia-Induced Kidney Injury. Mediators Inflamm 2015;2015:726243. [PMID: 26273142 DOI: 10.1155/2015/726243] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
13 Freedman SB, Xie J, Neufeld MS, Hamilton WL, Hartling L, Tarr PI, Nettel-Aguirre A, Chuck A, Lee B, Johnson D, Currie G, Talbot J, Jiang J, Dickinson J, Kellner J, MacDonald J, Svenson L, Chui L, Louie M, Lavoie M, Eltorki M, Vanderkooi O, Tellier R, Ali S, Drews S, Graham T, Pang XL; Alberta Provincial Pediatric Enteric Infection Team (APPETITE). Shiga Toxin-Producing Escherichia coli Infection, Antibiotics, and Risk of Developing Hemolytic Uremic Syndrome: A Meta-analysis. Clin Infect Dis 2016;62:1251-8. [PMID: 26917812 DOI: 10.1093/cid/ciw099] [Cited by in Crossref: 116] [Cited by in F6Publishing: 95] [Article Influence: 19.3] [Reference Citation Analysis]
14 Werber D, King LA, Müller L, Follin P, Buchholz U, Bernard H, Rosner B, Ethelberg S, de Valk H, Höhle M. Associations of age and sex with the clinical outcome and incubation period of Shiga toxin-producing Escherichia coli O104:H4 infections, 2011. Am J Epidemiol 2013;178:984-92. [PMID: 23935124 DOI: 10.1093/aje/kwt069] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
15 Acosta AA, Hogg RJ. Rasburicase for hyperuricemia in hemolytic uremic syndrome. Pediatr Nephrol 2012;27:325-9. [PMID: 22089328 DOI: 10.1007/s00467-011-2047-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
16 Kellner T, Parsons B, Chui L, Berenger BM, Xie J, Burnham CA, Tarr PI, Lee BE, Nettel-Aguirre A, Szelewicki J, Vanderkooi OG, Pang XL, Zelyas N, Freedman SB. Comparative Evaluation of Enteric Bacterial Culture and a Molecular Multiplex Syndromic Panel in Children with Acute Gastroenteritis. J Clin Microbiol 2019;57:e00205-19. [PMID: 30971465 DOI: 10.1128/JCM.00205-19] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
17 Tarr GAM, Chui L, Lee BE, Pang XL, Ali S, Nettel-Aguirre A, Vanderkooi OG, Berenger BM, Dickinson J, Tarr PI, Drews S, MacDonald J, Kim K, Freedman SB. Performance of Stool-testing Recommendations for Acute Gastroenteritis When Used to Identify Children With 9 Potential Bacterial Enteropathogens. Clin Infect Dis 2019;69:1173-82. [PMID: 30517612 DOI: 10.1093/cid/ciy1021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
18 Seifert ME, Tarr PI. Therapy: Azithromycin and decolonization after HUS. Nat Rev Nephrol 2012;8:317-8. [PMID: 22549228 DOI: 10.1038/nrneph.2012.87] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
19 Balestracci A, Martin SM, Toledo I, Alvarado C, Wainsztein RE. Dehydration at admission increased the need for dialysis in hemolytic uremic syndrome children. Pediatr Nephrol 2012;27:1407-10. [PMID: 22476204 DOI: 10.1007/s00467-012-2158-0] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
20 Wong CS, Mooney JC, Brandt JR, Staples AO, Jelacic S, Boster DR, Watkins SL, Tarr PI. Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis. Clin Infect Dis. 2012;55:33-41. [PMID: 22431799 DOI: 10.1093/cid/cis299] [Cited by in Crossref: 166] [Cited by in F6Publishing: 140] [Article Influence: 16.6] [Reference Citation Analysis]
21 Picard C, Burtey S, Bornet C, Curti C, Montana M, Vanelle P. Pathophysiology and treatment of typical and atypical hemolytic uremic syndrome. Pathologie Biologie 2015;63:136-43. [DOI: 10.1016/j.patbio.2015.03.001] [Cited by in Crossref: 30] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
22 Freedman SB, Eltorki M, Chui L, Xie J, Feng S, MacDonald J, Dixon A, Ali S, Louie M, Lee BE, Osterreicher L, Thull-Freedman J. Province-Wide Review of Pediatric Shiga Toxin-Producing Escherichia coli Case Management. J Pediatr 2017;180:184-190.e1. [PMID: 27745751 DOI: 10.1016/j.jpeds.2016.09.013] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
23 Tarr PI, Sadler JE, Chandler WL, George JN, Tsai H. Should all adult patients with diarrhoea-associated HUS receive plasma exchange? The Lancet 2012;379:516. [DOI: 10.1016/s0140-6736(12)60225-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
24 Menne J, Kielstein J, Wenzel U, Stahl R. Therapie des typischen hämolytisch-urämischen Syndroms: Erkenntnisse aus dem E.-coli-Ausbruch 2011. Internist 2012;53:1420-30. [DOI: 10.1007/s00108-012-3107-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
25 Giordano M, Baldassarre ME, Palmieri V, Torres DD, Carbone V, Santangelo L, Gentile F, Panza R, Di Mauro F, Capozza M, Di Mauro A, Laforgia N. Management of STEC Gastroenteritis: Is There a Role for Probiotics? Int J Environ Res Public Health 2019;16:E1649. [PMID: 31083597 DOI: 10.3390/ijerph16091649] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
26 Trachtman H, Austin C, Lewinski M, Stahl RA. Renal and neurological involvement in typical Shiga toxin-associated HUS. Nat Rev Nephrol 2012;8:658-69. [PMID: 22986362 DOI: 10.1038/nrneph.2012.196] [Cited by in Crossref: 129] [Cited by in F6Publishing: 113] [Article Influence: 12.9] [Reference Citation Analysis]
27 Karpman D, Loos S, Tati R, Arvidsson I. Haemolytic uraemic syndrome. J Intern Med 2017;281:123-48. [DOI: 10.1111/joim.12546] [Cited by in Crossref: 72] [Cited by in F6Publishing: 65] [Article Influence: 12.0] [Reference Citation Analysis]
28 Bitzan M, Lapeyraque A. Postinfectious Hemolytic Uremic Syndrome. In: Geary DF, Schaefer F, editors. Pediatric Kidney Disease. Berlin: Springer Berlin Heidelberg; 2016. pp. 653-731. [DOI: 10.1007/978-3-662-52972-0_26] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
29 Schindler EI, Sellenriek P, Storch GA, Tarr PI, Burnham CA. Shiga toxin-producing Escherichia coli: a single-center, 11-year pediatric experience. J Clin Microbiol 2014;52:3647-53. [PMID: 25078916 DOI: 10.1128/JCM.01231-14] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
30 Giordano P, Netti GS, Santangelo L, Castellano G, Carbone V, Torres DD, Martino M, Sesta M, Di Cuonzo F, Resta MC, Gaeta A, Milella L, Chironna M, Germinario C, Scavia G, Gesualdo L, Giordano M. A pediatric neurologic assessment score may drive the eculizumab-based treatment of Escherichia coli-related hemolytic uremic syndrome with neurological involvement. Pediatr Nephrol 2019;34:517-27. [PMID: 30362078 DOI: 10.1007/s00467-018-4112-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
31 Croxen MA, Law RJ, Scholz R, Keeney KM, Wlodarska M, Finlay BB. Recent advances in understanding enteric pathogenic Escherichia coli. Clin Microbiol Rev 2013;26:822-80. [PMID: 24092857 DOI: 10.1128/CMR.00022-13] [Cited by in Crossref: 644] [Cited by in F6Publishing: 333] [Article Influence: 80.5] [Reference Citation Analysis]
32 Mele C, Remuzzi G, Noris M. Hemolytic uremic syndrome. Semin Immunopathol 2014;36:399-420. [PMID: 24526222 DOI: 10.1007/s00281-014-0416-x] [Cited by in Crossref: 92] [Cited by in F6Publishing: 67] [Article Influence: 11.5] [Reference Citation Analysis]
33 Jandhyala DM, Vanguri V, Boll EJ, Lai Y, McCormick BA, Leong JM. Shiga toxin-producing Escherichia coli O104:H4: an emerging pathogen with enhanced virulence. Infect Dis Clin North Am 2013;27:631-49. [PMID: 24011834 DOI: 10.1016/j.idc.2013.05.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
34 Tarr PI, Freedman SB. Why antibiotics should not be used to treat Shiga toxin-producing Escherichia coli infections. Curr Opin Gastroenterol 2022;38:30-8. [PMID: 34871193 DOI: 10.1097/MOG.0000000000000798] [Reference Citation Analysis]
35 Shane AL, Mody RK, Crump JA, Tarr PI, Steiner TS, Kotloff K, Langley JM, Wanke C, Warren CA, Cheng AC, Cantey J, Pickering LK. 2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea. Clin Infect Dis. 2017;65:e45-e80. [PMID: 29053792 DOI: 10.1093/cid/cix669] [Cited by in Crossref: 144] [Cited by in F6Publishing: 101] [Article Influence: 36.0] [Reference Citation Analysis]
36 Goldwater PN, Bettelheim KA. Treatment of enterohemorrhagic Escherichia coli (EHEC) infection and hemolytic uremic syndrome (HUS). BMC Med 2012;10:12. [PMID: 22300510 DOI: 10.1186/1741-7015-10-12] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 5.9] [Reference Citation Analysis]
37 Freedman SB, Lee BE, Louie M, Pang XL, Ali S, Chuck A, Chui L, Currie GR, Dickinson J, Drews SJ, Eltorki M, Graham T, Jiang X, Johnson DW, Kellner J, Lavoie M, MacDonald J, MacDonald S, Svenson LW, Talbot J, Tarr P, Tellier R, Vanderkooi OG. Alberta Provincial Pediatric EnTeric Infection TEam (APPETITE): epidemiology, emerging organisms, and economics. BMC Pediatr 2015;15:89. [PMID: 26226953 DOI: 10.1186/s12887-015-0407-7] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
38 Zhang W, Bielaszewska M, Bauwens A, Fruth A, Mellmann A, Karch H. Real-time multiplex PCR for detecting Shiga toxin 2-producing Escherichia coli O104:H4 in human stools. J Clin Microbiol 2012;50:1752-4. [PMID: 22337987 DOI: 10.1128/JCM.06817-11] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
39 Spinale JM, Ruebner RL, Copelovitch L, Kaplan BS. Long-term outcomes of Shiga toxin hemolytic uremic syndrome. Pediatr Nephrol 2013;28:2097-105. [DOI: 10.1007/s00467-012-2383-6] [Cited by in Crossref: 110] [Cited by in F6Publishing: 81] [Article Influence: 12.2] [Reference Citation Analysis]
40 Karpman D. Management of Shiga toxin-associated Escherichia coli-induced haemolytic uraemic syndrome: randomized clinical trials are needed. Nephrol Dial Transplant 2012;27:3669-74. [PMID: 23114892 DOI: 10.1093/ndt/gfs456] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
41 Pang JX, Singh J, Freedman SB, Xie J, Hu J. Improving follow-up testing in children with Shiga toxin-producing Escherichia coli through provision of a provider information sheet. Aust J Prim Health 2020;26:479-83. [PMID: 33296623 DOI: 10.1071/PY20136] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Kampmeier S, Berger M, Mellmann A, Karch H, Berger P. The 2011 German Enterohemorrhagic Escherichia Coli O104:H4 Outbreak-The Danger Is Still Out There. Curr Top Microbiol Immunol 2018;416:117-48. [PMID: 30062592 DOI: 10.1007/82_2018_107] [Cited by in Crossref: 8] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
43 Bielaszewska M, Mellmann A, Bletz S, Zhang W, Köck R, Kossow A, Prager R, Fruth A, Orth-höller D, Marejková M, Morabito S, Caprioli A, Piérard D, Smith G, Jenkins C, Čurová K, Karch H. Enterohemorrhagic Escherichia coli O26:H11/H−: A New Virulent Clone Emerges in Europe. Clinical Infectious Diseases 2013;56:1373-81. [DOI: 10.1093/cid/cit055] [Cited by in Crossref: 91] [Cited by in F6Publishing: 84] [Article Influence: 10.1] [Reference Citation Analysis]
44 Mody RK, Griffin PM. Editorial Commentary : Increasing Evidence That Certain Antibiotics Should Be Avoided for Shiga Toxin–Producing Escherichia coli Infections: More Data Needed. Clin Infect Dis 2016;62:1259-61. [DOI: 10.1093/cid/ciw101] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
45 McKee RS, Tarr PI, Dietzen DJ, Chawla R, Schnadower D. Clinical and Laboratory Predictors of Shiga Toxin-Producing Escherichia coli Infection in Children With Bloody Diarrhea. J Pediatric Infect Dis Soc 2018;7:e116-22. [PMID: 29617871 DOI: 10.1093/jpids/piy025] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
46 Loconsole D, Giordano M, Centrone F, Accogli M, Casulli D, De Robertis AL, Morea A, Quarto M, Parisi A, Scavia G, Chironna M, On Behalf Of The Bloody Diarrhea Apulia Working Group. Epidemiology of Shiga Toxin-Producing Escherichia coli Infections in Southern Italy after Implementation of Symptom-Based Surveillance of Bloody Diarrhea in the Pediatric Population. Int J Environ Res Public Health 2020;17:E5137. [PMID: 32708640 DOI: 10.3390/ijerph17145137] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
47 Ho NK, Henry AC, Johnson-Henry K, Sherman PM. Pathogenicity, host responses and implications for management of enterohemorrhagic Escherichia coli O157:H7 infection. Can J Gastroenterol 2013;27:281-5. [PMID: 23712303 DOI: 10.1155/2013/138673] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
48 Ko H, Maymani H, Rojas-Hernandez C. Hemolytic uremic syndrome associated with Escherichia coli O157:H7 infection in older adults: a case report and review of the literature. J Med Case Rep 2016;10:175. [PMID: 27301547 DOI: 10.1186/s13256-016-0970-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
49 Chokoshvili O, Lomashvili K, Malakmadze N, Geleishvil M, Brant J, Imnadze P, Chitadze N, Tevzadze L, Chanturia G, Tevdoradze T, Tsertsvadze T, Talkington D, Mody RK, Strockbine N, Gerber RA, Maes E, Rush T. Investigation of an outbreak of bloody diarrhea complicated with hemolytic uremic syndrome. J Epidemiol Glob Health 2014;4:249-59. [PMID: 25455642 DOI: 10.1016/j.jegh.2014.03.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
50 Trachtman H. HUS and TTP in Children. Pediatr Clin North Am 2013;60:1513-26. [PMID: 24237985 DOI: 10.1016/j.pcl.2013.08.007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 3.1] [Reference Citation Analysis]
51 Lin CY, Xie J, Freedman SB, McKee RS, Schnadower D, Tarr PI, Finkelstein Y, Desai NM, Lane RD, Bergmann KR, Kaplan RL, Hariharan S, Cruz AT, Cohen DM, Dixon A, Ramgopal S, Powell EC, Kilgar J, Michelson KA, Bitzan M, Yen K, Meckler GD, Plint AC, Balamuth F, Bradin S, Gouin S, Kam AJ, Meltzer JA, Hunley TE, Avva U, Porter R, Fein DM, Louie JP, Tarr GAM; Pediatric Emergency Research Canada (PERC) and Pediatric Emergency Medicine Collaborative Research Committee (PEMCRC) STEC Study Group. Predicting Adverse Outcomes for Shiga Toxin-Producing Escherichia coli Infections in Emergency Departments. J Pediatr 2021;232:200-206.e4. [PMID: 33417918 DOI: 10.1016/j.jpeds.2020.12.077] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Travert B, Rafat C, Mariani P, Cointe A, Dossier A, Coppo P, Joseph A. Shiga Toxin-Associated Hemolytic Uremic Syndrome: Specificities of Adult Patients and Implications for Critical Care Management. Toxins (Basel) 2021;13:306. [PMID: 33925836 DOI: 10.3390/toxins13050306] [Reference Citation Analysis]
53 Cody EM, Dixon BP. Hemolytic Uremic Syndrome. Pediatric Clinics of North America 2019;66:235-46. [DOI: 10.1016/j.pcl.2018.09.011] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 12.0] [Reference Citation Analysis]
54 Tarr GAM, Oltean HN, Phipps AI, Rabinowitz P, Tarr PI. Strength of the association between antibiotic use and hemolytic uremic syndrome following Escherichia coli O157:H7 infection varies with case definition. Int J Med Microbiol 2018;308:921-6. [PMID: 30257808 DOI: 10.1016/j.ijmm.2018.06.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
55 Volk CG, Cusmano PM, Bower RJ, Sanders T, Maves RC. Volume Resuscitation and Progression to Organ Failure in Shiga Toxin-Producing Escherichia coli Infection in Adults. Crit Care Explor 2021;3:e0423. [PMID: 34036274 DOI: 10.1097/CCE.0000000000000423] [Reference Citation Analysis]
56 Bagga A, Khandelwal P, Mishra K, Thergaonkar R, Vasudevan A, Sharma J, Patnaik SK, Sinha A, Sethi S, Hari P, Dragon-Durey MA; Indian Society of Pediatric Nephrology. Hemolytic uremic syndrome in a developing country: Consensus guidelines. Pediatr Nephrol 2019;34:1465-82. [PMID: 30989342 DOI: 10.1007/s00467-019-04233-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
57 Grisaru S. Management of hemolytic-uremic syndrome in children. Int J Nephrol Renovasc Dis 2014;7:231-9. [PMID: 24966691 DOI: 10.2147/IJNRD.S41837] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
58 Loconsole D, Giordano M, Laforgia N, Torres D, Santangelo L, Carbone V, Parisi A, Quarto M, Scavia G, Chironna M; Bloody Diarrhea Apulia Working Group. Case-management protocol for bloody diarrhea as a model to reduce the clinical impact of Shiga toxin-producing Escherichia coli infections. Experience from Southern Italy. Eur J Clin Microbiol Infect Dis 2020;39:539-47. [PMID: 31776873 DOI: 10.1007/s10096-019-03755-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
59 Manrique-Caballero CL, Peerapornratana S, Formeck C, Del Rio-Pertuz G, Gomez Danies H, Kellum JA. Typical and Atypical Hemolytic Uremic Syndrome in the Critically Ill. Crit Care Clin 2020;36:333-56. [PMID: 32172817 DOI: 10.1016/j.ccc.2019.11.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
60 Zumbrun SD, Melton-Celsa AR, O'Brien AD. When a healthy diet turns deadly. Gut Microbes 2014;5:40-3. [PMID: 23989728 DOI: 10.4161/gmic.26263] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
61 Mody RK, Gu W, Griffin PM, Jones TF, Rounds J, Shiferaw B, Tobin-d'angelo M, Smith G, Spina N, Hurd S, Lathrop S, Palmer A, Boothe E, Luna-gierke RE, Hoekstra RM. Postdiarrheal Hemolytic Uremic Syndrome in United States Children: Clinical Spectrum and Predictors of In-Hospital Death. The Journal of Pediatrics 2015;166:1022-9. [DOI: 10.1016/j.jpeds.2014.12.064] [Cited by in Crossref: 55] [Cited by in F6Publishing: 42] [Article Influence: 7.9] [Reference Citation Analysis]
62 Derad I, Obermann B, Katalinic A, Eisemann N, Knobloch JK, Sayk F, Wellhöner P, Lehnert H, Solbach W, Süfke S, Steinhoff J, Nitschke M. Hypertension and mild chronic kidney disease persist following severe haemolytic uraemic syndrome caused by Shiga toxin-producing Escherichia coli O104:H4 in adults. Nephrol Dial Transplant 2016;31:95-103. [PMID: 26180049 DOI: 10.1093/ndt/gfv255] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
63 McKee RS, Schnadower D, Tarr PI, Xie J, Finkelstein Y, Desai N, Lane RD, Bergmann KR, Kaplan RL, Hariharan S, Cruz AT, Cohen DM, Dixon A, Ramgopal S, Rominger A, Powell EC, Kilgar J, Michelson KA, Beer D, Bitzan M, Pruitt CM, Yen K, Meckler GD, Plint AC, Bradin S, Abramo TJ, Gouin S, Kam AJ, Schuh A, Balamuth F, Hunley TE, Kanegaye JT, Jones NE, Avva U, Porter R, Fein DM, Louie JP, Freedman SB; Pediatric Emergency Medicine Collaborative Research Committee and Pediatric Emergency Research Canada. Predicting Hemolytic Uremic Syndrome and Renal Replacement Therapy in Shiga Toxin-producing Escherichia coli-infected Children. Clin Infect Dis 2020;70:1643-51. [PMID: 31125419 DOI: 10.1093/cid/ciz432] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
64 Freedman SB, Grisaru S, Xie J, Samuel S, Dixon A, Plint AC, Schnadower D; Pediatric Emergency Research Canada (PERC) and the Pediatric Emergency Medicine Collaborative Research Committee (PEM CRC). Management of Shiga toxin producing Escherichia coli-infected children: A multi-national, multi-specialty survey. J Paediatr Child Health 2018;54:390-7. [PMID: 29111613 DOI: 10.1111/jpc.13778] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
65 Davis TK, McKee R, Schnadower D, Tarr PI. Treatment of Shiga toxin-producing Escherichia coli infections. Infect Dis Clin North Am 2013;27:577-97. [PMID: 24011831 DOI: 10.1016/j.idc.2013.05.010] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 4.2] [Reference Citation Analysis]
66 Harkins VJ, Mcallister DA, Reynolds BC. Shiga-Toxin E. coli Hemolytic Uremic Syndrome: Review of Management and Long-term Outcome. Curr Pediatr Rep 2020;8:16-25. [DOI: 10.1007/s40124-020-00208-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]